報價延遲最少15分鐘:2026/03/10 06:01 EDT
盤前時段
|
||||
|
26.88 
|
|
|
常規時段 (已結束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
26.81
|
|
|
| 價值評估 |
|
盈利(現時/預測)
1.36/2.81
|
|
企業價值
214.62B
|
| 資產負債 |
|
每股賬面淨值
15.21
|
| 現金流量 |
|
現金流量率
0.08
|
| 損益表 |
|
收益
62.58B
|
|
每股收益
12.05
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor. |
